Advances for the Hepatitis A virus antigen production using a virus strain with codon frequency optimization adjustments in specific locations by Chavarria-Miró, Gemma et al.
fmicb-12-642267 February 14, 2021 Time: 16:53 # 1
ORIGINAL RESEARCH





de México (CINVESTAV), Mexico
Reviewed by:
Carlos Sandoval-Jaime,
Instituto de Biotecnología Universidad
Nacional Autonoma de México,
Mexico
Graham John Belsham,




†These authors have contributed
equally to this work
Specialty section:
This article was submitted to
Virology,
a section of the journal
Frontiers in Microbiology
Received: 15 December 2020
Accepted: 26 January 2021
Published: 18 February 2021
Citation:
Chavarria-Miró G,
de Castellarnau M, Fuentes C,
D’Andrea L, Pérez-Rodríguez F-J,
Beguiristain N, Bosch A, Guix S and
Pintó RM (2021) Advances
for the Hepatitis A Virus Antigen
Production Using a Virus Strain With
Codon Frequency Optimization
Adjustments in Specific Locations.
Front. Microbiol. 12:642267.
doi: 10.3389/fmicb.2021.642267
Advances for the Hepatitis A Virus
Antigen Production Using a Virus
Strain With Codon Frequency
Optimization Adjustments in Specific
Locations
Gemma Chavarria-Miró†, Montserrat de Castellarnau†, Cristina Fuentes†,
Lucía D’Andrea, Francisco-Javier Pérez-Rodríguez, Nerea Beguiristain, Albert Bosch,
Susana Guix and Rosa M. Pintó*
Enteric Virus Laboratory, Department of Genetics, Microbiology and Statistics, School of Biology, Institute of Nutrition
and Food Safety, Campus Torribera, University of Barcelona, Barcelona, Spain
The available cell-adapted hepatitis A virus (HAV) strains show a very slow replication
phenotype hampering the affordable production of antigen. A fast-growing strain
characterized by the occurrence of mutations in the internal ribosome entry site (IRES),
combined with changes in the codon composition has been selected in our laboratory.
A characterization of the IRES activity of this fast-growing strain (HM175-HP; HP) vs.
its parental strain (HM175; L0) was assessed in two cell substrates used in vaccine
production (MRC-5 and Vero cells) compared with the FRhK-4 cell line in which its
selection was performed. The HP-derived IRES was significantly more active than the
L0-derived IRES in all cells tested and both IRES were more active in the FRhK-4 cells.
The translation efficiency of the HP-derived IRES was also much higher than the L0-
derived IRES, particularly, in genes with a HP codon usage background. These results
correlated with a higher virus production in a shorter time for the HP strain compared
to the L0 strain in any of the three cell lines tested, and of both strains in the FRhK-4
cells compared to Vero and MRC-5 cells. The addition of wortmannin resulted in the
increase of infectious viruses and antigen in the supernatant of FRhK-4 infected cells,
independently of the strain. Finally, the replication of both strains in a clone of FRhK-4
cells adapted to grow with synthetic sera was optimal and again the HP strain showed
higher yields.
Keywords: hepatitis A, HAV, codon composition, IRES, vaccine, FRhK-4, MRC-5, Vero
INTRODUCTION
Hepatitis A outbreaks are on the rise. Recently, a huge outbreak has hit the men-having-sex-with-
men (MSM) group across Europe with over 4,000 cases (Beebeejaun et al., 2017; Freidl et al., 2017;
Werber et al., 2017; Ecdc., 2018). Likewise, in the US, outbreaks among people who use drugs,
people experiencing homelessness and the MSM group, have acquired vast dimensions with over
30,000 cases and 300 casualties1.
1www.cdc.gov/hepatitis/outbreaks/2017March-HepatitisA.htm
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The control of these outbreaks has been hampered by low
vaccination coverage and by vaccine shortages, which have
sometimes been overcome by restricting the number of vaccine
doses and their content. However, while these measures attempt
to avoid as much as possible the spread of the outbreaks
and to protect the patients’ health, they may prompt the
selection of vaccine-escape virus variants (Pintó and Bosch, 2019;
Sabrià et al., 2019).
Vaccine shortages may be due to higher-than-expected
demand and/or interruptions in supply caused by production
problems (Hinman et al., 2006). Production of large amounts of
antigens, required for inactivated vaccines, is still a critical step,
particularly for viruses with poor growth in cell culture such as
the hepatitis A virus (HAV) (Lemon et al., 1992). Several strains
of HAV have been adapted to replicate in vitro, including the HM-
175, CR-326, GBM, TZ84, Lv-8, YN5, and RG-SB strains (Lemon
et al., 2017), but production of industrial batches require large
scale-ups resulting in very high costs.
The slow growth of HAV in cell culture is the consequence of
the combination of at least three factors: its inefficient internal
ribosome entry site (IRES) in directing translation (Brown et al.,
1994; Whetter et al., 1994), its inability to induce the cellular
protein synthesis shutoff (Ali et al., 2001), and its deviated codon
usage with respect to the cell codon usage (Aragonès et al., 2010;
Pintó et al., 2018). Altogether may result in competition for the
translational machinery and tRNAs, which additionally may not
be well adapted to the virus requirements, contributing to the
modestly productive growth of HAV in cell culture.
A fast-growing strain of HAV, termed HM-175-HP, derived
from the HM-175 strain has been recently selected (Pérez-
Rodríguez et al., 2016). The HM-175 strain was adapted to
grow in conditions of artificially induced transcription shutoff
by treating the cells with actinomycin D (AMD), and two
populations long adapted to moderate and high levels of shutoff
were selected (D’Andrea et al., 2019). Competition experiments
between these two populations, enabled the rescue of the HM-
175-HP clone (Pérez-Rodríguez et al., 2016). This strain acquired
three mutations in the IRES and changed the codon frequency
particularly in the VP1 capsid coding region. The IRES became
more active, and the new codons were optimized with respect the
codon usage. The complete selection process was performed on
the FRhK-4 (Fetal Rhesus kidney) cell line.
Most HAV inactivated vaccines are produced in human
embryonic diploid fibroblasts (MRC-5, 2BS, and KMB17 cells)
or in continuous cell lines derived from the African green
monkey (Vero cells). The World Health Organization (WHO)
guidelines on vaccine production standardization2 recommend
testing for the presence of adventitious agents in the cells as well
as in sera or any other reagent susceptible to be contaminated,
such as the trypsin. Additionally, testing for oncogenicity and
tumorigenicity is also a recommendation. The vaccine based in
the HM-175 strain is produced in MRC-5 cells, whose seed stocks
production was overseen by the WHO Expert Committee on
Biological Standardization and are in the WHO Reference Cell
Bank. Nevertheless, these stocks are diminishing and due to both
2https://www.who.int/biologicals/vaccines/cell_substrates/en/
technical and ethical issues, it is extremely difficult to derive novel
human diploid fibroblasts from fetal lung tissues (Chen et al.,
2017). The continuous Vero cell line could also be used, but it
has been suggested that tumorigenesis may be induced at high
passages (Andreani et al., 2017).
The different cell substrates are associated with variations in
the efficiency of the final product purification, and steps for
removal of residual cellular constituents are especially important.
In fact, the HAV antigen used for vaccine production is usually
obtained from cell lysates since it is not efficiently released into
the culture supernatant (Bishop et al., 1994). However, since
the discovery of the HAV egress pathway (Feng et al., 2013),
new strategies to improve the virus release into the supernatant
may be designed.
In this study, we present data on the comparative translation
rate, growth and virus release to the supernatant of the HM-
175 and HM-175-HP strains in different cell substrates, which




Three different cell lines were used throughout this study: FRhK-
4 cells (Fetal Rhesus kidney epithelial), MRC-5 cells (Medical
Research Council cell strain 5; human diploid lung fibroblasts),
and Vero cells (African green monkey kidney epithelial).
These cells were grown in minimum essential medium (MEM)
supplemented with fetal bovine serum (FBS) at concentrations
of 15, 10, and 5%, for the FRhK-4, MRC-5, and Vero lines,
respectively. The post-infection (p.i.) media contained 2% FBS.
Two previously characterized HAV strains were used
throughout this study: HM-175-L0 (L0 thereafter) adapted
to grow in the normal conditions of no cellular shutoff, and
HM-175-HP (HP thereafter) adapted to grow in conditions of
moderate transcription shutoff (Costafreda et al., 2014; Pérez-
Rodríguez et al., 2016). Both populations were derived from the
HM-175 strain (Gust et al., 1985).
Viral stocks were regularly produced in FRhK-4 cells using
a multiplicity of infection (MOI) of 0.1. For HP, 0.05 µg/ml of
AMD (Sigma), was added in the p.i. media to induce a 60–70%
inhibition of the cell DNA transcription (Aragonès et al., 2010).
Virus infectious titers were obtained by infecting microtiter
plates of FRhK-4 cells with serial 10-fold dilutions of virus
supernatants in the absence of AMD (Costafreda et al., 2014).
The plates were incubated at 37◦C in a CO2 incubator and
the development of HAV-induced cytopathic effect (CPE) was
observed for 10 days. Titers were expressed as the Tissue Culture
Infectious Dose 50 (TCID50) per ml of supernatant.
In vitro Assays for the Determination of
the IRES Activity and the Translation
Efficiency
The bicistronic vector G1RC bears the Renilla reniformis
luciferase gene (RLuc), whose translation is cap-dependent,
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and the Photinus pyralis (firefly) luciferase gene (FLuc), whose
translation is dependent on the HAV IRES (Mackiewicz
et al., 2010). The G1RC vector was modified by directed
mutagenesis to include two restriction sites (MscI and KpnI)
to allow the cloning of genes just after the IRES and
before the FLuc gene (Supplementary Figure S1), and the
new plasmid was called G1RCMsKp (Pérez-Rodríguez et al.,
2016). The G1RCMsKp vector was further modified through
the introduction of the mutations required to match the
L0 IRES and subsequently with the mutations identifying
the HP IRES (D’Andrea et al., 2019). These latter vectors
were used to determine the IRES activity. Additionally, a
fragment of the VP1 coding region was cloned in each of
these vectors, just upstream of the FLuc gene and under
the IRES translation control, and was used to determine
the efficiency of translation. This VP1 fragment corresponded
to the 50% of the total VP1 length, spanning nucleotides
2,394–2,852, differing in its codon composition between the
L0 and the HP strains (D’Andrea et al., 2019), and with
the highest Relative Codon Deoptimization Index deviation
between both strains (Pérez-Rodríguez et al., 2016). Due
to the low activity of the HAV IRES, we focused on this
fragment to technically improve the detection of translation
efficiency differences.
Monolayers of cells grown in 96 well microtiters were
transfected with the different vectors. DNA was resuspended in
Opti-MEM I (Thermo Fisher Scientific) at a concentration of
0.01 µg/µl and X-tremeGENE HP DNA Transfection Reagent
(Roche) was added at a 4% (v:v) concentration. After incubating
for 15 min at room temperature, 25 µl of this suspension was
added to each well. Cells were incubated for a further 30 min at
room temperature and finally 60 µl of post-transfection medium
(Opti-MEM I) were added. After 24 hours the bioluminescence
activity was measured with the Dual-Glo Luciferase Assay
System (Promega) and detected with a luminometer (Lumat
LB 9507, Berthold Technologies). Light emission was measured
10 min after addition of each substrate and integrated over
a 10 s interval.
Three different experiments, each including two replicas,
were performed for the determination of both the IRES activity
and the translation efficiency (in the absence and presence
of 0.05 µg/ml of AMD), respectively, and the results were
figured as the mean and standard error of the FLuc/RLuc
ratio of the six determinations. As negative controls, cells
transfected with the digested vector alone were included. The
ratio FLuc/RLuc was used to balance differences on transfection
efficiency, transcription rate and mRNA export efficacy of the
different vectors.
Growth Curves
Virus growth curves were performed in FRhK-4 and MRC-5
cells incubated at 37◦C using a multiplicity of infection (MOI)
of 0.1. The HAV growth kinetics in Vero cells was performed
at the permissive temperature of 33◦C, using a MOI of 5.
Additionally, the replication curve in the FRhK-4-BK cell-clone
adapted to grow in synthetic sera, was also performed using MOIs
of 0.01, 0.1, and 5.
The growth curves of the HP strain were made in the presence
of 0.05 µg/ml AMD in all cell substrates except for the MRC-
5 cell line.
Induction of Virus Release Into the Cell
Supernatant of FRhK-4 Cells
FRhK-4 cells were infected using a MOI of 1. At 24 h
p.i., monolayers were washed twice with PBS, and fresh
medium containing bafilomycin or wortmaninn (Sigma-Aldrich)
at concentrations of 60 and 50 nM, respectively, was added;
wortmannin was refreshed every 6 h. Drug concentrations were
the highest granting an 80% cell viability. In parallel, monolayers
of infected cells were identically processed but the refreshing
medium did not contain any drug. Twelve hours after the
addition of the drugs (36 h p.i.), supernatants from infected-
untreated and infected-treated cells were collected, and viral
titers were determined by TCID50 as above described. Three
experiments with two replicas each were performed.
Additionally, the kinetics of virus release in the presence
of wortmaninn was ascertained at longer times (12, 24, and
48 h of treatment), following the same procedure and refreshing
the drug every 6 h.
Sucrose-Iodixanol Gradients
Supernatants from infected cell cultures were centrifuged at
1,500 g for 10 min at 4◦C to pellet any cellular debris, and clarified
by centrifuging twice at 10,000g for 30 min at 4◦C. Viruses were
concentrated by ultracentrifugation at 100,000g for 1 h at 4◦C.
The pellets were resuspended in 1 ml of PBS and loaded onto pre-
formed 6–50% iodixanol-(OptiPrep, Axis-Shield) sucrose step
gradients, which were centrifuged at 205,000g for 2 h and 45 min
at 4◦C (SW41 Ti rotor in a Beckman Coulter Optima L-90K
centrifuge). Approximately 20 fractions of 0.5 ml each were
collected from the gradients and the density of each fraction was
determined using a refractometer.
RNA from gradient fractions was extracted using the
Nucleospin RNA Virus Extraction Kit (Macherey-Nagel) and
HAV genome copy numbers were determined by a previously
described Real-Time RT-PCR of the 5’ non-coding region
(Costafreda et al., 2006), using the RNA UltraSense One-Step
Quantitative RT-PCR System (Invitrogen).
HAV Antigen Detection
L0 and HP antigens in the supernatants of infected cells in the
presence or absence of wortmannin were analyzed by direct
sandwich ELISA. Supernatants were treated with 1% NP-40 for
30 min at 37◦C and three 30 s sonication cycles at 60 W. Mock-
infected FRhK-4 cell supernatants identically processed were
used as negative controls.
A human convalescent-phase serum was used for both
capture (unlabeled antibodies) and detection of the HAV capsids
(peroxidase-labeled antibodies). A cut-off level was established
corresponding to the mean ±3SD of the unspecific recognition
of mock-infected FRhK-4 cell supernatants.
Three different virus stocks of the L0 and HP strains produced
in the presence or absence of wortmannin and three replicas
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FIGURE 1 | Comparative activity of L0 and HP IRES-types in MRC-5, Vero, and FRhK-4 cell lines. In the box plot diagrams, the box represents the 25th, 50th, and
75th percentiles, the whiskers the 5th and 95th percentiles, and the red dashed line the mean. (A) Activity of L0 and HP IRES-types in each cell line. *Significant
statistical differences (p < 0.001, p = 0.002 and p < 0.001, in MRC-5, Vero, and FRhK-4 cells, respectively), assessed by the Student’s t-test. (B) Comparative
activity of L0 IRES-type and HP IRES-type in each of the three cell lines. *Significant statistical differences (p < 0.001) assessed by the One-way ANOVA test.
FIGURE 2 | Translation efficiency of a fragment of the VP1 gene, whose codon composition is different in the L0 and HP strains, under the control of L0 and HP
IRES-types and in the absence or presence of actinomycin D (AMD) in FRhK-4 cells. In the box plot diagrams, the box represents the 25th, 50th, and 75th
percentiles, the whiskers the 5th and 95th percentiles, and the red dashed line the mean. (A) Translation efficiency of the VP1 fragment from the L0 strain.
*Significant statistical differences (p < 0.001) assessed by the Student’s t-test. (B) Translation efficiency of the VP1 fragment from the HP strain. *Significant
statistical differences (p < 0.001) assessed by the Student’s t-test.
of each stock were analyzed. The percentage of positive replicas
for each stock and the number of ELISA units in each positive
replica estimated.
Statistical Analysis
Statistical differences between the IRES activity of the L0 and
HP types in the different cell lines, the translation efficiency
of the L0 and HP IRES types in the different codon usage
backgrounds and in the presence and absence of AMD, the virus
release of the L0 and HP virus populations in the presence or
absence of drugs, and the convalescent-phase serum recognition
of the L0 and HP capsids were assessed using the Student’s
t-test (unpaired two-tailed) after verifying the normality of data
with the Kolmogorov-Smirnov test. When normality failed the
Mann-Whitney Rank Sum Test (SigmaPlot version 10) was
applied. The difference of the IRES activity of a particular type
in the different cells lines was tested with the One way ANOVA
(SigmaPlot version 10).
RESULTS
Activity of the Internal Ribosome Entry
Site (IRES) Derived From the HM-175 (L0)
and HM-175-HP (HP) Strains in Different
Cell Substrates as an Indication of Virus
Growth
It has been described that the replication rate of HAV, in some
cell lines, is controlled to a significant degree by the efficiency
of translation, particularly by the Internal Ribosome Entry Site
(IRES) activity (Funkhouser et al., 1999).
Frontiers in Microbiology | www.frontiersin.org 4 February 2021 | Volume 12 | Article 642267
fmicb-12-642267 February 14, 2021 Time: 16:53 # 5
Chavarria-Miró et al. Improving Hepatitis A Virus Yields
FIGURE 3 | Growth curves of L0 (red) and HP (green) strains in MRC-5, FRhK-4 and Vero cells.
In an attempt to identify the best cell substrate for the
production of high antigen yields, we tested the activity of the
L0- and HP-derived IRES, in three different cell lines: MRC-
5, Vero and FRhK-4. The HP-derived IRES was significantly
more efficient than the L0-derived in directing translation in all
cells tested (p < 0.001, p = 0.002 and p < 0.001, in MRC-5,
Vero and FRhK-4 cells, respectively) (Figure 1A). The average
increase of the IRES activity between the HP and L0 was of
around 1.5, 1.1, and 1.4 in MRC-5, Vero and FRhK-4 cells,
respectively. Additionally, independently of the IRES-type, the
translation efficiency was significantly higher in FRhK-4 cells
(p < 0.001) (Figure 1B).
Efficiency of the L0- and HP-Derived
IRES in Directing the Translation of
Capsid Regions With Different Codon
Usage Backgrounds in the FRhK-4 Cells
The fast-growing phenotype of the HP strain is likely due to
the inter-connected action of: (i) the mutations in the IRES,
(ii) the right combination of codons in the capsid region, and
(iii) the higher availability of resources in conditions of AMD
induced transcription shutoff. To confirm the role of each
of these factors we comparatively determined the translation
efficiency after inter-changing the L0- and HP-derived IRES
in codon usage backgrounds from the L0 and HP strains,
in conditions of absence and presence of AMD. We took
advantage of four bicistronic vectors (L0-IRES with a VP1
genome fragment from the L0 strain, HP-IRES with a VP1
genome fragment from the HP strain, L0-IRES with a VP1
genome fragment from the HP strain and HP-IRES with a VP1
genome fragment from the L0 strain) which were transfected
into FRhK-4 cells.
Comparing the IRES-type effects, it could be concluded
that the HP-derived IRES significantly (p < 0.001) increased
(1.3 X) the translation of a VP1 genome fragment with a
L0 codon usage background only in the absence of AMD
(Figure 2A). Additionally, this increase was even more relevant
and significant when translating the same VP1 fragment but
with an HP codon usage background, in both the absence
(3.4 X) and presence (1.6 X) of AMD (Figure 2B) with a
p < 0.001. Finally, comparing exclusively the effect of the
addition of AMD, there was a significant (p < 0.001) increase
of the translation efficiency in all cases; however the magnitude
of such increase was much more relevant in the HP codon
usage background.
The actual virus strains have a L0-type IRES with a L0 codon
usage background (L0 strain) and a HP-type IRES with a HP
codon usage background (HP strain). In this scenario, the single
factor to play with to increase the antigen yield is the addition
of AMD. While the HP translation efficiency showed an increase
of 18 X in the presence of AMD (p < 0.0001), in L0 this
increase was of only 1.64 X (p < 0.001). Overall, the HP strain
in the presence of AMD shows an efficiency of translation 100X
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FIGURE 4 | Effect of wortmannin on virus release into supernatants of
FRhK-4 cells. (A) Virus titers of L0 and HP strains in the absence and
presence of wortmannin (W). (B) Fold increase in virus titers in the
supernatants with wortmannin treatment.
higher (p < 0.001) compared to the L0 strain in the absence of
AMD (Figure 2).
These results confirm that the HP strain grown in FRhK-
4 cells in the presence of AMD is of great potential for
antigen production.
Comparative Virus Production of the L0
and HP Strains in MRC-5, Vero and
FRhK-4 Cells
Virus productivity of L0 and HP strains in MRC-5 and FRhK-4
cells after infecting them at 37◦C and a MOI of 0.1 was compared.
L0 strain was grown in the absence of AMD, while the HP strain
was grown in the absence of AMD in MRC-5 cells and in the
presence of AMD in FRhK-4 cells.
As expected from the IRES activity results, the highest yields in
the shortest time were obtained using the FRhK-4 cell line, while
the lowest yields were observed in the MRC-5 cells (Figure 3).
Compared to L0, the HP strain showed maximum titer increases
of 0.28 and 0.53 Log10 TCID50/ml in MRC-5, and FRhK-4
cells, respectively.
Replication in Vero cells at the permissive temperature of
33◦C was also analyzed. L0 and HP strains were grown in the
absence or presence of AMD, respectively, using a MOI of 5.
Yields of the HP strain were also higher (Figure 3), with a
maximum average increase of 0.25 Log10 TCID50/ml.
Virus Release Into the Supernatants
From L0 and HP-Infected FRhK-4 Cells
HAV antigens for vaccine and serology test kits production are
commonly obtained by lysis of infected cells with detergents,
followed by a concentration/purification step. However, the
recent discoveries describing that HAV egress from cells as
quasi-enveloped virions (eHAV) (Feng et al., 2013), i.e., capsids
inside exosomes (McKnight et al., 2017), opens the possibility
to improve antigen production by using culture supernatants
instead of cell extracts.
In an attempt to increase the release of eHAV virions into the
cell culture supernatant, we added bafilomycin or wortmannin at
24 h, p.i., to interfere with the traffic pathways, and analyzed the
eHAV infectious titers in cell supernatants after 12 h of treatment.
While bafilomycin inhibited the release of eHAV particles (fold
increase of 0.31 ± 0.24 and 0.82 ± 0.32 for the L0 and HP
strains, respectively), wortmannin improved their release (fold
increase of 2.14 ± 0.83 and 5.24 ± 0.56 for the L0 and HP
strains, respectively).
Additionally, we analyzed the effect of wortmannin after
longer treatments (Figure 4). Wortmannin induced a significant
increase of the eHAV egress, for the L0 population only after
24 h (p = 0.006) and 48 h (p = 0.016) treatments (Figure 4A). In
contrast, for the HP population the egress significantly increased
at shorter treatment times, of 12 h (p < 0.001) and 24 h
(p = 0.026) (Figure 4A). The average fold-increases were of
2.15, 3.70, and 4.80 for L0 population and of 5.28, 2.03, and
1.5 for the HP population at 12, 24, and 48 h of treatment,
respectively (Figure 4B).
The effect of the wortmannin was further ascertained
through the analysis of iodixanol-sucrose gradients of culture
supernatants after 48 and 24 h of treatment for the L0 and HP
populations, respectively. In both cases there was a clear increase
of the genome copy numbers in the fractions with densities of
1.10–1.13 g/cm3, which correspond to the eHAV virions, after
the wortmannin treatment. In the specific gradient shown in
Figure 5, increases of around 5.0X and 2.5X were estimated for
the L0 and HP populations at 48 and 24 h, respectively. These
results indicate that the increments of infectivity observed in the
supernatant of wortmannin-treated cells, are indeed due to an
improved egress of the eHAV particles.
Finally, we evaluated how the improvement of eHAV release
into the supernatants turned out in antigen yields. Again,
wortmannin treatment significantly increased (p < 0.001) both,
the number of positive supernatant replicas and the number
of ELISA units in the positive replicas, independently of the
population (Figure 6).
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FIGURE 5 | Sucrose-Iodixanol gradients of viruses present in the supernatant of FRhK-4 cells infected with the L0 and HP strains in the presence and absence of
wortmannin (W). Naked and quasi-enveloped particles have densities of 1.20–1.25 and 1.06–1.12 g/cm3, respectively. The highest number of genome copies of
quasi-enveloped particles in the absence or presence of wortmannin are depicted by dashed pink and cyan lines, respectively.
FIGURE 6 | Antigen detection in supernatants of FRhK-4 infected cells in the
absence or presence of wortmannin (W). (A) Mean percentage of replicas
positive by an ELISA detecting the HAV antigen. (B) Mean of ELISA units
present in the positive samples.
Growth Curves of the L0 and HP Strains
in FRhK-4 Cells Adapted to Synthetic
Sera
The most expensive reagent to produce viruses in cell culture is
fetal calf serum (FBS), particularly when using substrates such as
the FRhK-4 cell line which require a supplement of 15% FBS.
From data obtained in this study, we can conclude that the
FRhK-4 cell substrate is the most permissive for the L0 and HP
strains replication. To make the production more affordable, we
tested the replication on a clone of the FRhK-4 cell line adapted to
grow in the presence of synthetic sera (FRhK-4-BK cells). Growth
kinetics for both populations was similar in FRhK-4 cells grown
with either synthetic sera (Figure 7) or FBS (Figure 3).
As expected, the higher the MOI the shorter the time to
achieve the maximum yields. Instead, a MOI as low as 0.01
combined with a replication time as long as 12 days yielded the
highest titers (Figure 7). The HP population did show higher
yields than the L0 population, particularly relevant when using
a MOI of 0.01 (Figure 7).
DISCUSSION
Genome recoding approaches have lately been used to attenuate
virus populations (Le Nouen et al., 2017, 2019), including codon
deoptimization (Cheng et al., 2015), codon-pair deoptimization
(Li et al., 2018; Mueller et al., 2020) and one-to-stop codons
(Moratorio et al., 2017; Carrau et al., 2019). The basis of
attenuation is the lower replication associated to a less efficient
translation, the increased cellular antiviral responses associated
to increases of CpG and UpA contents, and the lower robustness
of the populations.
While these strategies are applicable to many different viruses,
HAV is an exception to the rule. HAV has a naturally deoptimized
codon usage (Sánchez et al., 2003), which contributes to a low
replication phenotype (D’Andrea et al., 2019). The underlying
basis of its deviated codon usage is the need for a finely tuned
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FIGURE 7 | Growth curves of L0 (red) and HP (green) strains in FRhK-4-BK cells at different MOIs.
translation of the capsid coding region, which requires the precise
location of clusters of rare codons (Aragonès et al., 2010). Rare
codons in the HAV genome belong to two types: truly rare (in
both the virus and the cell genomes) and rare by competition
(rare in the virus genome but abundant in the cell genome).
Since HAV is not able to shutdown the cellular protein synthesis
it would compete for the tRNAs and the abundant tRNAs,
pairing with the abundant cell codons, will become scarce (Pintó
et al., 2018). Therefore, HAV has evolved avoiding the use of
these codons, and thus, designing a re-coding strategy for HAV
becomes extremely complicated. Instead, we adopted a classical
approach of serial passaging of the virus in changing conditions
of shutoff and selected the HM175-HP strain, which has adjusted
the codon composition, mostly in the VP1 coding region, and
in turn has acquired a more active IRES (Pérez-Rodríguez et al.,
2016). Since we did only analyze the mutant swarm in a fragment
of the VP1 coding region which showed an adjustment of the
codon composition toward its optimization, we cannot rule out
the possibility of codon frequency changes in other regions, and
particularly in the region coding for the non-structural proteins.
Nevertheless, mutations detected in the consensus sequence of
the HP strain showed the same pattern of codon frequency
changes observed in the mutant swarm of their ancestors, which
did not show significant variations in the non-structural proteins
coding region with respect the L0 population grown in the
absence of AMD (Aragonès et al., 2010).
Production of HAV antigens remains challenging due to the
low yields generated by the available cell-adapted strains. Our
study shows that, the HM-175-HP strain would be a good
candidate to produce a more affordable inactivated vaccine. Its
IRES is more efficient than the IRES of the L0 strain in all cell
substrates and is particularly active in translating genes of its
same codon usage background. The use of wortmannin improves
the eHAV egress and their accumulation in the supernatant,
being a clear advantage for antigen production and purification.
Relevant for vaccine production, is the very short half-life of
wortmannin in tissue culture (Holleran et al., 2003), which would
prevent toxicity issues. Although more stable than wortmannin,
AMD is indeed highly sensitive to light (Budavari, 1996),
providing a means for its inactivation.
Replication of the HM175-HP strain is optimal in the FRhK-
4 cell line, which is not in use in vaccine manufacturing.
This cell line can be adapted to grow in synthetic sera
without any loss in HAV yield, consequently it could be a
good cell substrate to produce HAV antigen. Similarly, it
has been proposed to be used for the large-scale production
of poliovirus (Dotti et al., 2017). Additionally, it has been
reported to be free of tumorigenic features (Dotti et al.,
2017) and of polyomavirus (Provost et al., 1984), the
adventitious agent that prevented the use of the fetal rhesus
cell lines for vaccine production (Klug et al., 2016). Moreover,
Next-Generation-Sequencing (NGS) technologies for the
detection of a broad range of viruses in combination with
complete and correctly annotated viral databases may expand
the range of cell substrates useful for vaccine production
(Khan et al., 2020).
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